ImageneBio (IMA) Interest Expenses (2020 - 2025)
ImageneBio (IMA) posted Interest Expenses of $1000.0 for Q4 2025, down 99.97% sequentially from $2.9 million in Q3 2025, and down 99.98% YoY from $4.1 million in Q4 2024.
ImageneBio (IMA) Interest Expenses (2020 - 2025) Analysis & Trends
ImageneBio has reported Interest Expenses for 6 years, with the latest figure at $1000.0 in Q4 2025.
- Quarterly Interest Expenses fell 99.98% year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 99.99% YoY) and the FY2025 annual result came in at $1000.0, down 100.0% from the prior year.
- Interest Expenses slipped to $1000.0 in Q4 2025 per IMA's latest filing, from $2.9 million in the prior quarter.
- Over five years, Interest Expenses peaked at $2.1 billion in Q2 2022 and troughed at $1000.0 in Q4 2025.
- A 5-year average of $170.7 million and a median of $3.5 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses jumped 5020.56% in 2022, then tumbled 99.98% in 2025.
- Over 5 years, Interest Expenses stood at $33.3 million in 2021, then sank by 94.71% to $1.8 million in 2022, then surged by 43.44% to $2.5 million in 2023, then surged by 61.48% to $4.1 million in 2024, then sank by 99.98% to $1000.0 in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $1000.0, $2.9 million, and $22000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | ImageneBio | 49.41 Mn | -85.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 4.08 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 629,000.00 |
| Sep 30, 2024 | 629,000.00 |
| Jun 30, 2024 | 476,000.00 |
| Jun 30, 2024 | 476,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Dec 31, 2023 | 2.53 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 4.06 Mn |
| Sep 30, 2023 | 4.06 Mn |